Widespread use of generic GLP-1 medications could help Ontario residents save money and lose weight while forcing the food ...

Novo Nordisk (NYSE:NVO) is advancing the launch of an oral version of Ozempic, expanding its GLP-1 diabetes franchise beyond injectable formats. The company is also seeking regulatory approvals to ...

Discovered using AI, a naturally occurring molecule appears to act directly in the brain’s appetite center. Scientists hope ...

Canada has approved its first generic semaglutide injection, potentially lowering costs and easing shortages of the blockbuster diabetes and weight-loss drug. The move comes as new studies raise ...

Novo Nordisk bets on oral Ozempic launch and pediatric label expansions to counter slowing demand, pricing pressure and ...

Forget free snacks in the break room. For Gen Z, choosing between jobs isn’t always about salary, paid time off or cushy ...

Health Canada has granted Dr. Reddy’s Laboratories a Notice of Compliance for a generic version of semaglutide injection, ...

As Ozempic trends surge, natural alternatives are gaining traction. But while certain foods may support satiety, the science ...

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear ...

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

Facial procedures are on the rise.

Health Canada approved on Tuesday the first generic version of Danish drugmaker Novo Nordisk's Ozempic drug. In a news ...